Form D · Pharmaceuticals
Cambridge Therapeutic Technologies, LLC
Teaneck, NJ · CIK 0001686168
Offering snapshot reported Oct 3, 2016 · SEC filing
- Reported sold
- $6M Offering amount: $7M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 19, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 3, 2016 | Initial | $6,000,000 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-271717
Source: Form D, filed Oct 3, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Dos Santos | Executive |
| John Klein | Director, Executive |
| Barry A. Posner | Director, Executive |
| Marc Wasserman | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
500 Frank W. Burr Boulevard Suite 4
Teaneck, NJ, 07666
Teaneck, NJ, 07666